Intracerebral haemorrhage expansion by 24 hours · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Recombinant activated factor VII showed no clear difference in intracerebral haemorrhage expansion by 24 hours compared with placebo/open control (low certainty).
1 finding from 1 review
Mood ‐ not reported · adults with acute spontaneous intracerebral haemorrhage associated with antiplatelet drug use
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive function ‐ not reported · adults with acute spontaneous intracerebral haemorrhage associated with antiplatelet drug use
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death or dependence (mRS 4 to 6) at day 90 · adults with acute spontaneous intracerebral haemorrhage associated with anticoagulant drug use
It is very uncertain whether summary of findings table ‐ Prothrombin complex concentrates changes death or dependence (mRS 4–6) compared with fresh frozen plasma (very low certainty).
1 finding from 1 review
Intracerebral haemorrhage expansion by 24 hours · adults with acute spontaneous intracerebral haemorrhage associated with anticoagulant drug use
It is very uncertain whether summary of findings table ‐ Prothrombin complex concentrates changes intracerebral haemorrhage expansion by 24 hours compared with fresh frozen plasma (very low certainty).
1 finding from 1 review
All serious adverse events · adults with acute spontaneous intracerebral haemorrhage associated with anticoagulant drug use
It is very uncertain whether summary of findings table ‐ Prothrombin complex concentrates changes all serious adverse events compared with fresh frozen plasma (very low certainty).
1 finding from 1 review
RR 0.27 [0.02, 3.74]
1 study · 5 participants
Very low
Death from any cause · adults with acute spontaneous intracerebral haemorrhage associated with anticoagulant drug use
It is very uncertain whether summary of findings table ‐ Prothrombin complex concentrates changes death from any cause compared with fresh frozen plasma (very low certainty).
1 finding from 1 review
Quality of life ‐ not reported · adults with acute spontaneous intracerebral haemorrhage associated with anticoagulant drug use
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mood ‐ not reported · adults with acute spontaneous intracerebral haemorrhage associated with anticoagulant drug use
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive function ‐ not reported · adults with acute spontaneous intracerebral haemorrhage associated with anticoagulant drug use
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
All serious adverse events · adults with acute spontaneous intracerebral haemorrhage
It is very uncertain whether summary of findings table ‐ Recombinant activated factor VII changes all serious adverse events compared with placebo/open control (very low certainty).
1 finding from 1 review
Death from any cause · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Recombinant activated factor VII showed no clear difference in death from any cause compared with placebo/open control (moderate certainty).
1 finding from 1 review
Quality of life ‐ not reported · adults with acute spontaneous intracerebral haemorrhage
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mood ‐ not reported · adults with acute spontaneous intracerebral haemorrhage
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cognitive function ‐ not reported · adults with acute spontaneous intracerebral haemorrhage
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death or dependence (mRS 4 to 6) at day 90 · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Antifibrinolytic drug(s) showed no clear difference in death or dependence (mRS 4–6) compared with placebo/open control (high certainty).
1 finding from 1 review
Intracerebral haemorrhage expansion by 24 hours · adults with acute spontaneous intracerebral haemorrhage
Summary of findings table ‐ Antifibrinolytic drug(s) leads to lower intracerebral haemorrhage expansion by 24 hours compared with placebo/open control (high certainty).
1 finding from 1 review
All‐cause death ( · people with acute ischemic stroke
Cerebrolysin or Cerebrolysin‐like agents showed no clear difference in all‐cause death ( compared with placebo (moderate certainty).
1 finding from 1 review
Non‐death attrition · people with acute ischemic stroke
It is very uncertain whether cerebrolysin or Cerebrolysin‐like agents changes non‐death attrition compared with placebo (very low certainty).
1 finding from 1 review
SAEs · people with acute ischemic stroke
Cerebrolysin or Cerebrolysin‐like agents showed no clear difference in total number of people with SAEs** compared with placebo (moderate certainty).
1 finding from 1 review